Jayalaxmi Suresh Babu

机构：Johns Hopkins University, Johns Hopkins Medicine, Cancer Clinic, Sidney Kimmel Comprehensive Cancer Center · ORCID：0009-0001-4919-1050

发表论文 34 篇 · 总被引 97 次 · h-index 5

代表论文

• A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages (2025 · OncoImmunology · 被引 18)
• Diminished immune cell adhesion in hypoimmune ICAM-1 knockout human pluripotent stem cells (2025 · Nature Communications · 被引 4)
• Supplementary Figure 5 from Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair–Proficient Colorectal Cancer (2025)
• Supplementary Table 7 from Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair–Proficient Colorectal Cancer (2025)
• Supplementary Figure 2 from Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair–Proficient Colorectal Cancer (2025)
• Supplementary Table 5 from Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair–Proficient Colorectal Cancer (2025)